Gene Therapy Halts Progression of Rare Genetic Condition in Young Boy

Dr. Jim Dowling, Staff Physician and Senior Scientist at SickKids, and CRDN Steering Committee member, and his team administered a first single-patient gene therapy trial that shows promise in halting the progression of SPG50.